H-CYTE, Inc. announced that on June 3, 2022, the Company closed its clinic in Scottsdale, Arizona. The Company has now closed all of its clinical operations in the autologous infusion therapy business which delivered treatments for patients with chronic respiratory and pulmonary disorders. The Company will continue to pursue regulatory approval of the device that was utilized in the treatment provided at the clinics.

The Company also has a continued interest in the commercialization of the denervex device. The Company has begun to transform itself into a biologics and therapeutic device incubator to bring new technologies to market.